News

Novo Nordisk Foundation Launches Denmark’s First AI Supercomputer to Accelerate Drug Discovery and Innovation

In a major step for Danish research and industry, the Novo Nordisk Foundation has introduced "Gefion," Denmark's first AI supercomputer, …

Continue ›››

Quris-AI Acquires Nortis to Enhance Drug Safety with Kidney-on-Chip Tech

Quris-AI, a company dedicated to enhancing drug safety prediction, has announced its acquisition of Kidney-on-Chip pioneer Nortis, also known as …

Continue ›››

Medable Launches Clinical Trial Platform on Google Cloud Marketplace, Expands AI Integration

Medable Inc. has launched its Digital and Decentralized Clinical Trial Platform on Google Cloud Marketplace, bringing advanced trial management and …

Continue ›››

Archon Biosciences Raises $20M to Develop AI-Enhanced "Antibody Cages" for New Therapeutics

Seattle’s Archon Biosciences, co-founded by David Baker, a recent Nobel Prize winner, has raised $20 million in seed funding to …

Continue ›››

Gene Therapy: Lexeo Therapeutics’ LX1001 Shows Promise for APOE4-Associated Alzheimer’s Disease

Lexeo Therapeutics recently presented interim findings from its ongoing Phase 1/2 trial of LX1001, a gene therapy targeting Alzheimer’s disease …

Continue ›››

Ataraxis AI Steps Forward in Precision Cancer Care With $4 Million in Seed Funding

Today, Ataraxis AI emerged from stealth with $4 million in seed funding to develop AI-driven cancer diagnostics aimed at advancing …

Continue ›››

Insilico Medicine and Sanofi Report AI-Enabled Milestone in Drug Discovery for Oncology

Insilico Medicine, a biotechnology company focused on AI-driven drug discovery, announced a milestone in its collaboration with Sanofi, targeting “undruggable” …

Continue ›››

Iambic Therapeutics Unveils Enchant AI to Predict Clinical Outcomes Using Preclinical Data

Iambic Therapeutics has announced the launch of Enchant, an AI platform designed to predict clinical outcomes from the earliest stages …

Continue ›››

Stem Cell Transplant 'Black Box' Unveiled in 31-Year Study of Blood Cells

A pioneering study has provided the first detailed insight into the long-term behavior of stem cells following transplants, offering new …

Continue ›››

Benchling Acquires PipeBio to Enhance AI-Powered Antibody Discovery

Benchling, a cloud-based R&D software provider, has acquired PipeBio, a bioinformatics company specializing in high-throughput sequence analysis for biologics discovery. …

Continue ›››

Laverock Therapeutics to Showcase New Data on Expanding Gene-Silencing Platform at ESGCT 2024

Following recent advancements in its gene-silencing technology, UK-based Laverock Therapeutics is set to present new data at the European Society …

Continue ›››

Life Biosciences Presents New Data on Epigenetic Reprogramming for Optic Neuropathies at AAO 2024

Life Biosciences, a biotech company advancing therapies to reverse aging-related diseases, shared new findings at the American Academy of Ophthalmology …

Continue ›››